智通财经APP讯，美佳音控股(06939)公布，预期该集团于2025年上半年取得公司拥有人应占净亏损约人 民币4000万元至6000万元，而2024年同期则为公司拥有人应占纯利约人民币40.5万元。 公告称，由盈转亏主要是由于受兼容打印机耗材芯片行业激烈竞争影响，集团兼容打印机耗材芯片业务 毛利率于有关期间大幅下降;为加强集团物联网芯片、网上销售等新业务的发展，集团于有关期间开展 了更多营销活动，导致销售及分销开支增加;因位于中华人民共和国的总部变更及撇销原材料成本，导 致集团行政开支增加;及集团于有关期间产生净经营亏损，导致资产减值拨备大幅增加。 ...

由于美国IDC的租金收入减少，以及信息家电业务销售订单整体呈下降趋势，毛利下跌56.1%至1650万 港元(2024年6月30日：3770万港元)。 裕兴科技(08005)发布截至2025年6月30日止6个月中期业绩，该集团取得收入4497.4万港元，同比减少 62.75%;公司拥有人应占亏损2999.2万港元，去年同期则取得溢利5315.7万港元;每股亏损1.21港仙。 ...

Core Viewpoint - Macro Medical Management (09906) anticipates a net loss attributable to shareholders not exceeding RMB 2 million for the six months ending June 30, 2025, compared to a net profit of approximately RMB 20 million for the six months ending June 30, 2024 [1] Group 1 - The expected shift from profit to loss is primarily due to a decrease in demand for inpatient medical services, leading to reduced revenue [1] - The actual settlement rate from the public medical insurance plan for the fiscal year 2024, completed in May 2025, was lower than the estimated settlement rate used in the consolidated financial statements for the year ending December 31, 2024, resulting in decreased inpatient service revenue [1] - The company further adjusted the estimated settlement rate for inpatient service revenue covered by the plan for the first half of 2025 downward due to the aforementioned discrepancies [1]

Core Viewpoint - The company expects to report a net loss attributable to shareholders of no more than RMB 2 million for the six months ending June 30, 2025, a significant decline from a net profit of approximately RMB 20 million for the same period in 2024 [1] Group 1: Financial Performance - The anticipated shift from profit to loss is primarily attributed to a decrease in demand for inpatient medical services, leading to reduced revenue [1] - The actual settlement rate from the 2024 public medical insurance plan, completed in May 2025, was lower than the estimated settlement rate used in the financial statements for the year ending December 31, 2024, resulting in decreased inpatient service revenue [1] - The company has further adjusted the estimated settlement rate for inpatient service revenue covered by the plan for the first half of 2025 downward [1]